Skip to main content
Erschienen in: Journal of Neurology 11/2020

13.06.2020 | Original Communication

Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis

verfasst von: Dana Pourzinal, Ji Hyun J. Yang, Gerard J. Byrne, John D. O’Sullivan, Leander Mitchell, Katie L. McMahon, David A. Copland, Nadeeka N. Dissanayaka

Erschienen in: Journal of Neurology | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The concept of Mild Cognitive Impairment (MCI) in Parkinson’s disease (PD) has shown the potential for identifying at-risk dementia patients. Identifying subtypes of MCI is likely to assist therapeutic discoveries and better clinical management of patients with PD (PWP). Recent cluster-based approaches have demonstrated dominance in memory and executive impairment in PD. The present study will further explore the role of memory and executive impairment and associated clinical features in non-demented PWP.

Method

A K-means cluster analysis was performed on ten “frontal” and “posterior” cognitive variables derived from a dataset of 85 non-demented PWP. The resulting cluster structure was chosen based on quantitative, qualitative, theoretical, and clinical validity. Cluster profiles were then created through statistical analysis of cognitive and clinical/demographic variables. A descriptive analysis of each cluster’s performance on a comprehensive PD-MCI diagnostic battery was also explored.

Results

The resulting cluster structure revealed four distinct cognitive phenotypes: (1) frontal-dominant impairment; (2) posterior-cortical-dominant impairment; (3) global impairment, and (4) cognitively intact. Demographic profiling revealed significant differences in the age, gender split, global cognitive ability, and motor symptoms between these clusters. However, there were no significant differences between the clusters on measures of depression, apathy, and anxiety.

Conclusion

These results validate the existence of distinct cognitive phenotypes within PD-MCI and encourage future research into their clinical trajectory and neuroimaging correlates.
Literatur
12.
Zurück zum Zitat Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Hilten JJV, LaPelle N (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170. https://doi.org/10.1002/mds.22340CrossRefPubMed Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Hilten JJV, LaPelle N (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170. https://​doi.​org/​10.​1002/​mds.​22340CrossRefPubMed
13.
18.
Zurück zum Zitat Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356. https://doi.org/10.1002/mds.24893CrossRefPubMedPubMedCentral Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356. https://​doi.​org/​10.​1002/​mds.​24893CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Delis D (2001) Delis Kaplan (D-KEFS) technical manual. San Antonio, TX Delis D (2001) Delis Kaplan (D-KEFS) technical manual. San Antonio, TX
20.
Zurück zum Zitat Benedict RHB, Brandt J (2007) Hopkin’s verbal learning test-revised/brief visuospatial memory test-revised: professional manual supplement. PAR, Lutz Benedict RHB, Brandt J (2007) Hopkin’s verbal learning test-revised/brief visuospatial memory test-revised: professional manual supplement. PAR, Lutz
21.
Zurück zum Zitat Golden CJ, Freshwater SM (2002) STROOP colour and word test: a manual for clinical and experimental uses. Stoelting, Wood Dale Golden CJ, Freshwater SM (2002) STROOP colour and word test: a manual for clinical and experimental uses. Stoelting, Wood Dale
22.
Zurück zum Zitat Lezak MD (2012) Neuropsychological assessment, 5th edn. Oxford University Press, New York Lezak MD (2012) Neuropsychological assessment, 5th edn. Oxford University Press, New York
25.
Zurück zum Zitat Kaplan E, Goodglass H, Weintraub S (1983) Boston naming test. Lea & Febiger, Philadelphia Kaplan E, Goodglass H, Weintraub S (1983) Boston naming test. Lea & Febiger, Philadelphia
30.
33.
Zurück zum Zitat Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K (2018) Cluster: cluster analysis basics and extensions. R package v2.0.7-1 Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K (2018) Cluster: cluster analysis basics and extensions. R package v2.0.7-1
Metadaten
Titel
Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis
verfasst von
Dana Pourzinal
Ji Hyun J. Yang
Gerard J. Byrne
John D. O’Sullivan
Leander Mitchell
Katie L. McMahon
David A. Copland
Nadeeka N. Dissanayaka
Publikationsdatum
13.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 11/2020
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-09977-z

Weitere Artikel der Ausgabe 11/2020

Journal of Neurology 11/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.